Roundtable
Marc P. Bonaca, MD, MPH
Professor
University of Colorado
Vascular Medicine
Aurora, Colorado, United States
Disclosure(s): 35Pharma, Inc.; Abbott Labratories; Agios Pharmaceuticals, Inc.; Alexion Pharmaceuticals; Amgen; Anthos Therapeutics, Inc.; Arrowhead Pharmaceuticals; Autonomy Bio, Inc.; Bayer; Bristol-Myers Squibb; Cleerly, Inc.; Cook Regentec: Grants/Research Support Recipient
Eidos Therapeutics, Inc.; EluraBio, Inc.; Esperion Therapeutics, Inc.; Faraday Pharmaceuticals, Inc.; Gasherbrum Bio, Inc.; Insmed; IsomAb Limited; JanOne Biotech Holdings, Inc.; Janssen Pharmaceuticals, Inc.; Lexicon Pharmaceuticals, Inc.: Grants/Research Support Recipient
Lilly USA; Medison Pharma; Merck Sharp & Dohme Corp.; Nectero Medical, Inc.; NewAmsterdam Pharma; Novartis Pharmaceuticals; Novo Nordisk, Inc.; Pfizer; Piper Sandler & Co; PPD Development; Prothena Biosciences; Sanofi; Silence Therapeutics: Grants/Research Support Recipient
Stealth BioTherapeutic, Inc.; Regeneron; Tourmaline Bio, Inc.; VarmX; Verve Therapeutics: Grants/Research Support Recipient